Dr. Jennifer Nelson explains how Kaiser Permanente scientists are helping the CDC and FDA keep an eye out for rare adverse events.
The investigational mRNA vaccine is also well tolerated, according to trial led by Kaiser Permanente Washington researcher and others.
Can lessons from Immunity Community help build acceptance of COVID-19 vaccines? Clarissa Hsu, PhD, thinks so.
Dr. Mike Jackson has long studied the spread of flu and effectiveness of vaccination at Kaiser Permanente Washington. And now… of COVID-19 too.
The benefits of vaccines far outweigh the risks. Still, the debate about the value of vaccines continues on. Here are some facts to help you make the right health decision for your child.
There’s a lot of information out there about the merits and risks of vaccines. Parents are rightly concerned about making the best choices for their children amid conflicting information.
How KPWHRI and its Institutional Review Board help potential study participants make informed decisions
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.